Polyplus-transfection has granted Merck rights to the prior use of PEI for transfection. Polyplus-transfection will also supply Merck sites worldwide with batches of high quality linear PEI ...

Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, and Blue Sky BioServices, a contract research organization (CRO) providing ...

Chemical transfection, which relies on the formation of a condensed complex of positively charged liposomal or non-liposomal reagents and negatively charged nucleic acids, is the most common method ...

Gene therapy involves the transfer of genetically modified materials into a patient's cells to correct abnormal genes associated with diseases (Sun, 2017). Recent advancements in gene therapy have ...

The demand for biopharmaceutical products continues to grow significantly, driven by the increasing availability of highly effective and potent medicines. This is coupled with the patient’s and ...

Accurate monitoring of nanoparticle size and growth is essential to ensure scalability in the development of transfection vectors for gene delivery. This study highlights how Spatially Resolved-DLS ...